Ignite Creation Date:
2025-12-24 @ 1:47 PM
Ignite Modification Date:
2025-12-24 @ 1:47 PM
Study NCT ID:
NCT00444795
Status:
COMPLETED
Last Update Posted:
2017-02-01
First Post:
2007-03-07
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene
Sponsor:
Pfizer
Organization:
Study Overview
Official Title:
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene
Status:
COMPLETED
Status Verified Date:
2016-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To monitor use in real practice including adverse events and efficacy on Sutent capsules (Sunitinib malate)
Detailed Description:
All the patients prescribed according to approved indications at contracted institutions
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: